CC - CIK 0001627223
The table below shows Chemours Co's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $563.00M | $613.00M | $502.00M | $464.00M | $596.00M | $604.00M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $645.00M | $817.00M | $813.00M | $704.00M | $825.00M | $788.00M |
| Inventory | $1.54B | $1.55B | $1.56B | $1.55B | $1.44B | $1.37B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.93B |
| $3.21B |
| $3.10B |
| $2.93B |
| $3.08B |
| $2.94B |
| Property, plant & equipment | $3.04B | $3.09B | $3.12B | $3.13B | $3.17B | $3.16B |
| Goodwill | $46.00M | $46.00M | $46.00M | $46.00M | $46.00M | $102.00M |
| Total assets | $7.27B | $7.57B | $7.49B | $7.39B | $7.46B | $7.25B |
| Accounts payable | $891.00M | $1.03B | $1.02B | $1.01B | $1.07B | $938.00M |
| Total current liabilities | $1.61B | $1.88B | $1.85B | $1.67B | $1.78B | $1.56B |
| Long-term debt | $4.10B | $4.10B | $4.10B | $4.06B | $3.99B | $3.95B |
| Total liabilities | $7.05B | $7.27B | $7.25B | $6.81B | $6.80B | $6.52B |
| Retained earnings | $1.18B | $1.31B | $1.26B | $1.66B | $1.76B | $1.83B |
| Total equity | $215.00M | $298.00M | $237.00M | $579.00M | $657.00M | $723.00M |